Ligand binding pocket of the human somatostatin receptor 5: Mutational analysis of the extracellular domains

Molecular Pharmacology

Volumn 52, Issue 5, 1997, Pages 807-814

  Greenwood, Michael T ^a,b   Hukovic, Nedim ^a,b   Kumar, Ujendra ^a,b   Panetta, Rosemarie ^a,b   Hjorth, Siv A ^c   Srikant, Coimbatore B ^a,b   Patel, Yogesh C ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; NEUROPEPTIDE; OCTREOTIDE; SEGLITIDE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SRIF 14; SRIF 28; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; DELETION MUTANT; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIGAND BINDING; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL;

EID: 0030817407     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.5.807     Document Type: Article

References (34)

1. Dohlman, H. G., J. Thorner, M. G. Caron, and R. J. Lefkowitz. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60:653-688 (1991).
2. Schertler, G. F. X., C. Villa, and R. Henderson. Projection structure of rhodopsin. Nature (Lond.) 362:770-772 (1993).
3. Baldwin, J. M. The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12:1693-1703 (1993).
4. Schwartz, T. W. Locating ligand-binding sites in 7TM receptors by protein engineering. Curr. Opin. Biotech. 5:434-444 (1994).
5. Houslay, M. D. G-protein linked receptors: a family probed by molecular cloning and mutagenesis procedures. Clin. Endocrinol. 36:525-534 (1992).
6. Balwin, J. M. Structure and function of receptors coupled to G proteins. Curr. Opin. Cell Biol. 6:180-190 (1994).
7. Strader, C. D., T. M. Fong, M. P. Graziano, and M. R. Tota. The family of G-protein-coupled receptors. FASEB J. 9:745-754 (1995).
8. Gether, U., T. E. Johansen, R. M. Snider, J. A. Lowe, X. Emonds-Alt, Y. Yokota, S. Nakanishi, and T. W. Schwartz. Binding epitopes for peptide and non-peptide ligands on the NK1 (substance P) receptor. Regul. Pept. 46:49-58 (1993).
9. Schwartz, T. W., and M. M. Rosenkilde. Is there a lock for all agonist keys in 7TM receptors? Trends Pharmacol. Sci. 17:213-216 (1996).
10. Patel, Y. C., M. T. Greenwood, R. Panetta, L. L. Demchyshyn, H. B. Niznik, and C. B. Srikant. The somatostatin receptor family: a mini review. Life Sci. 57:1249-1265 (1995).
11. Panetta, R., M. T. Greenwood, A. Warszynska, L. L. Demchyshyn, R. Day, H. B. Niznik, C. B. Srikant, and Y. C. Patel. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28. Mol. Pharmacol. 45:417-427 (1994).
12. Patel, Y. C., and C. B. Srikant. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstrl-5). Endocrinology 135:2814-2817 (1994).
13. Bruns, C., G. Weckbecker, F. Raulf, K. Kaupmann, P. Schoefter, D. Hoyer, and H. Lübbert. Molecular pharmacology of somatostatin-receptor subtypes. Ann. N. Y. Acad. Sci. 733:138-146 (1994).
14. Kaupmann, K., C. Bruns, F. Raulf, H. P. Weber, H. Mattes, and H. Lübbert. Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201-995 for the SSTR2 somatostatin receptor. EMBO J. 14:727-735 (1995).
15. Nehring, R. B., W. Meyerhof, and D. Richter. Aspartic acid residue 124 in the third transmembrane domain of the somatostatin receptor subtype 3 is essential for somatostatin-14 binding. DNA Cell Biol. 14:939-944 (1995).
16. Strnad, J., and J. R. Hadcock. Identification of a critical aspartate residue in transmembrane domain three necessary for the binding of somatostatin to the somatostatin receptor SSTR2. Biochem. Biophys. Res. Commun. 216:913-921 (1995).
17. Pradier, L., J. Menager, J. Le Guern, M.-D. Bockj, E. Heuillet, V. Fardin, C. Garret, A. Doble, and J.-F. Mayaux. Septide: an agonist for the NK1 receptor acting at a site distinct from substance P. Mol. Pharmacol. 45: 287-293 (1994).
18. Gingrich, J. A., and M. G. Caron. Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16:299-321 (1993).
19. Humphrey, P. P. A., P. Hartig, and D. Hoyer. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 14:233-236 (1993).
20. Hjorth, S. A., H. T. Schambye, W. J. Greenlee, and T. W. Schwartz. Identification of peptide binding residues in the extracellular domains of the AT1 receptor. J. Biol. Chem. 269:30953-30959 (1994).
21. Kozak, M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15:8125-8148 (1987).
22. Johansen, T. E., M. S. Scholler, S. Tolstoy, and T. W. Schwartz. Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors. FEBS Lett. 267:289-294 (1990).
23. Probst, W. C., L. A. Snyder, D. I. Schuster, J. Brosius, and S. C. Sealfon. Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol. 11:1-20 (1992).
24. Fitzpatrick, V. D., and R. L. Vandlen. 6Agonist selectivity determinants in somatostatin receptor subtypes I and II. J. Biol. Chem. 269:24621-24626 (1994).
25. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68 (1989).
26. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59 (1989).
27. Srikant, C. B., and Y. C. Patel. Somatostatin receptors: identification and characterization in rat brain membranes. Proc. Natl. Acad. Sci. USA 78:3930-3934 (1981).
28. Hukovic, N., R. Panetta, U. Kumar, and Y. C. Patel. Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): subtype selective internalization or upregulation. Endocrinology 137: 4046-4049 (1996).
29. Han, B., and A. H. Tashjian, Jr. Importance of extracellular domains for ligand binding in the thyrotropin-releasing hormone receptor. Mol. Endocrinol. 9:1708-1719 (1995).
30. Unson, C. G., A. M. Cypess, H. N. Kim, P. K. Goldsmith, C. J. L. Carruthers, R. B. Merrifield, and T. P. Sakmar. Characterization of deletion and truncation mutants of the rat glucagon receptor: seven transmembrane segments are necessary for receptor transport to the plasma membrane and glucagon binding. J. Biol. Chem. 270:27720-27727 (1995).
31. Rens-Domiano, S., and T. Reisine. Structural analysis and functional role of the carbohydrate component of somatostatin receptors. J. Biol. Chem. 266:20094-20102 (1991).
32. Rosenkilde, M. M., M. Cahir, U. Gether, S. A. Hjorth, and T. W. Schwartz. Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. J. Biol. Chem. 269:28160-28164 (1994).
33. Metzger, T. G., and D. M. Ferguson. On the role of extracellular loops of opioid receptors in conferring ligand selectivity. FEBS Lett. 375:1-4 (1995).
34. Flanagan, C. A., I. I. Becker, J. S. Davidson, I. K. Wakefield, W. Zhou, S. C. Sealfon, and R. P. Millar. Glutamate 301 of the mouse gonadotropin-releasing hormone receptor confers specificity for arginine 8 of mammalian gonadotropin-releasing hormone. J. Biol. Chem. 269:22636-22641 (1994).